Yang, G.; Jiang, M.; Liu, L.; Jia, D.; Feng, J.; Luo, Y.; Ye, T.; Xia, L.; Liu, H.; Zhang, Z.;
et al. The Synergistic Risk of Insulin Resistance and Renal Dysfunction in Acute Coronary Syndrome Patients After Percutaneous Coronary Intervention. J. Cardiovasc. Dev. Dis. 2025, 12, 427.
https://doi.org/10.3390/jcdd12110427
AMA Style
Yang G, Jiang M, Liu L, Jia D, Feng J, Luo Y, Ye T, Xia L, Liu H, Zhang Z,
et al. The Synergistic Risk of Insulin Resistance and Renal Dysfunction in Acute Coronary Syndrome Patients After Percutaneous Coronary Intervention. Journal of Cardiovascular Development and Disease. 2025; 12(11):427.
https://doi.org/10.3390/jcdd12110427
Chicago/Turabian Style
Yang, Guoshu, Maoling Jiang, Lin Liu, Dongyue Jia, Jie Feng, Yan Luo, Tao Ye, Long Xia, Hanxiong Liu, Zhen Zhang,
and et al. 2025. "The Synergistic Risk of Insulin Resistance and Renal Dysfunction in Acute Coronary Syndrome Patients After Percutaneous Coronary Intervention" Journal of Cardiovascular Development and Disease 12, no. 11: 427.
https://doi.org/10.3390/jcdd12110427
APA Style
Yang, G., Jiang, M., Liu, L., Jia, D., Feng, J., Luo, Y., Ye, T., Xia, L., Liu, H., Zhang, Z., Fu, J., Cai, L., Chen, Q., & Xiong, S.
(2025). The Synergistic Risk of Insulin Resistance and Renal Dysfunction in Acute Coronary Syndrome Patients After Percutaneous Coronary Intervention. Journal of Cardiovascular Development and Disease, 12(11), 427.
https://doi.org/10.3390/jcdd12110427
